Pharmacovigilance is a Public Health activity aiming to identify, quantify, evaluate and prevent possible hazards derived form the use of medicines.
Pharmaceutical companies, Marketing Authorisation Holders (MAH) of their product portfolio, are obliged to have and maintain a Pharmacovigilance system that enables the management of suspected adverse reactions reported by healthcare professionals and/or consumers.
For Faes Farma Group, one of our main goals is to guarantee the maximum safety of all the drug products we commercialise.
Would you like to report a potential suspected adverse reaction to a Faes Farma group marketed drug product?
If you are a healthcare professional and wish to report a suspected adverse reaction to any of the medicines commercialised by FAES FARMA Group click here.
If you are a consumer or patient and wish to report a suspected adverse reaction to any of the medicines commercialised by FAES FARMA Group click here.
Pharmacovigilance Unit, FAES FARMA Group.
Parque empresarial Cristalia. Calle Vía de los Poblados 3, Edificio 2, 2º Izquierda, 28033. Madrid, España (Spain).
Tel.: + (34) 914680800 / +(34) 944818300
*Please note, we cannot respond to questions about general medical information or questions regarding your personal medical condition. If you have questions about a specific medical condition, please consult a healthcare professional.